BASP1P1

Across TCGA pan-cancer cohorts, BASP1P1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of BASP1P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where BASP1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BASP1P1 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KIRP, KICH, and KIRC are the cancer types where BASP1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BASP1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Male	III,IV	+1.985	<.001	8	view →
KICH	All	II,III,IV	−0.596	<.001	8	view →
KIRC	Male	II,III,IV	+1.332	<.001	7	view →
UCEC	All	III,IV	+1.947	.001	6	view →
HNSC	All	II,III,IV	+0.062	.033	4	view →
BRCA	All	All	+0.016	.044	4	view →
LUSC	All	All	+0.201	.001	3	view →
LIHC	All	All	+0.041	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

BASP1P1–KIRP

Open the KIRP breakdown →